ALVO vs TSHA: stock comparison and AI forecast
Alvotech (ALVO) and Taysha Gene Therapies, Inc. (TSHA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALVO Alvotech
- Market Cap
- $1.62B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
TSHA Taysha Gene Therapies, Inc.
- Market Cap
- $1.33B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ALVO is 1.2 times larger than TSHA by market capitalization ($1.62B against $1.33B).
- ALVO turns -13.3% of its revenue into net income, against -2728.0% for TSHA.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALVO | TSHA |
|---|---|---|
| Market Cap | $1.62B | $1.33B |
| P/B Ratio | – | 3.44x |
| EPS | $-0.89 | $-0.38 |
| Book Value/Share | – | $1.19 |
| Revenue/Share | $4.54 | $0.02 |
| FCF/Share | $-1.43 | $-0.41 |
Profitability & Margins
| Metric | ALVO | TSHA |
|---|---|---|
| ROE | – | -38.6% |
| ROA | -14.5% | -31.8% |
| ROIC | 18.6% | -34.5% |
| Gross Margin | 61.3% | – |
| Operating Margin | 13.6% | -2792.3% |
| Net Margin | -13.3% | -2728.0% |
| EBT Margin | -7.8% | -2792.3% |
| Tax Rate | -70.1% | 0.0% |
Financial Health
| Metric | ALVO | TSHA |
|---|---|---|
| Current Ratio | 1.89x | 17.76x |
| Quick Ratio | 1.16x | – |
| D/E Ratio | – | 0.21x |
| Financial Leverage | – | 1.21x |
| Interest Coverage | – | -32.8x |
| Working Capital | $270M | $435M |
Cash Flow
| Metric | ALVO | TSHA |
|---|---|---|
| Operating Cash Flow | -$345M | -$132M |
| Free Cash Flow | -$510M | -$133M |
| Capital Spending | -$165M | -$380K |
| FCF/Sales | -31.5% | -2417.0% |
| CapEx/Sales | 10.2% | 7.0% |
Operational Efficiency
| Metric | ALVO | TSHA |
|---|---|---|
| Asset Turnover | 1.09x | 0.01x |
| Inventory Turnover | 2.8x | – |
| Fixed Assets Turnover | 4.5x | 2.3x |
| Days Inventory | 128 days | – |
| Payables Period | 74 days | – |
Income Statement
| Metric | ALVO | TSHA |
|---|---|---|
| Total Revenue | $1.62B | $5M |
| Operating Income | $220M | -$153M |
| Net Income | -$216M | -$150M |
| R&D Expense | $546M | $123M |
| Cost of Goods Sold | $625M | – |
Dividend & Shareholder Information
| Metric | ALVO | TSHA |
|---|---|---|
| Shares Outstanding | 356M | 326M |
ALVO vs TSHA: stock comparison and AI forecast
Which is bigger, ALVO or TSHA?
ALVO is 1.2 times larger than TSHA by market capitalization ($1.62B against $1.33B).
Which one does Intratio's AI model rank higher, ALVO or TSHA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.